Alex Tung Memorial Innovative Research Award for Embryonal Rhabdomyosarcoma Studies

This Innovative Research Award supports research on rhabdomyosarcoma, an aggressive and highly malignant form of cancer that develops from skeletal muscle cells that have failed to fully differentiate. It occurs mostly in children under age 18. The application process and guidelines will be the same as with the general IRA (see above) except that the applicant must document how the project specifically targets rhabdomyosarcoma or other related sarcomas. Funding will be up to $25,000. This award is funded through the generosity of Sarah Young, whose son Alex Tung died of rhabdomyosarcoma when he was 31 years old. Read more about Alex and Sarah here. 

The annual application deadline is March 3, 2025. 

SUBMISSION OF APPLICATION:

1. 3-page project description which includes a budget and budget justification.
2. 5-page NIH style biosketch, including the personal statement the PI's and Co-PI's cancer-relevant experience and why this project is relevant to the JCRC's mission.
3. All documents must be Ariel font 12pt 1-inch margin.
4. Contact the Johnson Cancer Research Center for any questions about the application process. 
5. Complete and submit the application electronically.
6. Include a 5-page biosketch(s) for PI and Co-PI's.
7. Please do not submit a truncated proposal for another funding source.
8. This grant mechanism must address Rhabdomyosarcoma.
9. Publications from the last 3 years which acknowledge funding from the Johnson Cancer Research Center.
10. Provide a 100-word summary, in lay language, of the work you propose.
11. Provide the names, affiliation and contact information of 5 experts (off K-State campus) who can review this application and don't have a conflict of interest with our program (no co-authorships, share grant applications or significant professional collaborations with the past 5 years).